The future of anticoagulation clinics

Journal of Thrombosis and Thrombolysis

Volumn 16, Issue 1-2, 2003, Pages 61-63

  Nutescu, Edith A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anticoagulation clinics; Antithrombotic agents; Oral direct thrombin inhibitors; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; MELAGATRAN; THROMBIN INHIBITOR; WARFARIN; XIMELAGATRAN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG INDICATION; DRUG MONITORING; DRUG USE; HEALTH CARE COST; HEALTH CENTER; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; LIVER DYSFUNCTION; MEDICAL PRACTICE; ORTHOPEDIC SURGERY; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; STROKE; THROMBOSIS; UNITED STATES; VENOUS THROMBOEMBOLISM; WORKLOAD;

AMBULATORY CARE FACILITIES; ANTICOAGULANTS; FORECASTING; HUMANS;

EID: 1842678155     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000014595.46367.89     Document Type: Article

References (16)

1. Nutescu E, Racine E. Traditional versus modern anticoagulant strategies: Summary of the literature. Am J Health Syst Pharm 2002;59(20; Suppl 6):S7-S14.
2. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S.
3. Berrettini M. Anticoagulation clinics: The Italian experience. Haematologica 1997;82(6):713-717.
4. Sam C, Speckman J, Moskowitz M, Ansell J. The Management of warfarin therapy by anticoagulation clinics: Results of a forum survey. Anticoagulation Forum Newsletter 2000;5(2):1-4.
5. Bongiorno R, Nutescu E. A national survey of anticoagulation clinics on the use of brand versus generic warfarin. Pharmacotherapy 1999;19(10):1204.
6. Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy: Experience with an anticoagulation clinic. Arch Intern Med 1984;144:1966-1968.
7. Charney R, Leddomado E, Rose DN, et al. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol 1988;18:197-206.
8. Bussey HI, Rospond RM, Quandt CM, et al. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic. Pharmacotherapy 1989;9:214-219.
9. Conte RR, Kehoe WA, Nielson N, et al. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm 1986;43:2460-2464.
10. Garabedian-Ruffalo SM, Gray DR, Sax MJ, et al. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-308.
11. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993;69:316-320.
12. Wilt VM, Gums JG, Ahmed OI, et al. Pharmacy operated anticoagulation. service: Improved outcomes in patients on warfarin. Pharmacotherapy 1995;15:732-779.
13. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic and usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Int Med 1998;158:1641-1647.
14. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-580.
15. Wahlander K, Lapidus L, Olsson CG, et al. Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis. Thromb Res 2002;107:93-99.
16. Steinmetzer T, Hauptmann J, Sturzebecher J. Advances in the development of thrombin inhibitors. Expert Opin Investig Drugs 2001;10:845-864.